Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe₂O₃ using photocatalytic degradation technique and its echo-biomedical applications.

ABSTRACT: The present paper evaluates the photocatalytic degradation (PCD) performance of the biofabricated hematite nanoparticles (α-HNPs) for the degradation approach of the Cefotaxime (Cfm). The optimum pH of the solution to achieve the best PCD was found to be 10.5. The kinetics study for the PCD of the Cfm via α-HNPs has been investigated and the reaction was found to be fellow pseudo-first-order at R² = 0.992. The mass loading impact of α-HNPs was investigated and estimated for the maximum degradation of Cfm 0.4 mg/mL. UV-Vis confirmed that α-HNPs had a direct transition bandgap at 3.78 eV at a maximum absorption wavelength of 362 nm with suspension stability for 7 days. The probable mechanism of the Cfm PCD via α-HNPs and the degradation pathway was conducted. The validation of the

SUBMITTER: Al-Hakkani MF 

PROVIDER: S-EPMC9279508 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature